Assoc. Prof. Alicia Morgans

Go Back

Medical Oncologist

  • Dana-Farber Cancer Institute
  • location United States

Dr Morgans is Genitourinary Medical Oncologist at Dana-Farber Cancer Institute, and Faculty in Medicine at Harvard Medical School in Boston, MA. She completed medical school and residency at the University of Pennsylvania School of Medicine, fellowship in Hematology/Oncology at Harvard’s Dana Farber Cancer Institute and Massachusetts General Hospital Cancer Center in Boston and earned a Master of Public Health at Vanderbilt University. Dr Morgans treats patients with prostate, bladder, and testicular cancer, and her research assesses complications of advanced prostate cancer survivorship and patient-centered treatment decision-making in advanced prostate cancer.

Assoc. Prof. Alicia Morgans has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AAA, Astellas, AstraZeneca, Bayer, Exelixis, Janssen, Myovant, Novartis, Pfizer, Sanofi and Telix. 

Programmes developed by Assoc. Prof. Alicia Morgans

eks
Experts Knowledge Share Video
Oncology 
Precision oncology in practice – testing through to treatment in lung and prostate cancer

Molecular testing challenges and optimal biomarker testing approaches in lung and prostate cancer

Experts
Prof. Fernando López-Ríos, Assoc. Prof. Alicia Morgans, Dr Herbert H. Loong
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock MIN
  • calendar May 2024

Educational programme supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.
micro-learning Micro learning

Module

2

of 2

module
Oncology 
PARP inhibitors in prostate cancer and the rationale behind combination treatment

Module 2 - Evolving landscape of PARPi in mCRPC: Combination with anti-androgens

Experts
Assoc. Prof. Alicia Morgans, Dr Pasquale Rescigno
Endorsed by
ZERO EAUN
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Oct 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca
micro-learning Micro learning

Module

1

of 2

module
Oncology 
PARP inhibitors in prostate cancer and the rationale behind combination treatment

Module 1 - PARP inhibitors in advanced prostate cancer

Experts
Assoc. Prof. Alicia Morgans, Dr Pasquale Rescigno
Endorsed by
ZERO EAUN
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jan 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca
podcast Podcast
Oncology 
Shared decision-making in nmCRPC – Treatment considerations to maintain quality of life

Brenda Martone, Nurse Practitioner is joined by Assoc. Prof.  Alicia Morgans from GU CONNECT to discuss shared decision-making in non-metastatic castration-resistant prostate cancer (nmCRPC) and the treatment considerations to maintain quality of life. 

Experts
Brenda Martone, Assoc. Prof. Alicia Morgans
  • download Downloadable
    Resources
  • clock MIN
  • calendar May 2022

Educational programme supported by an Independent Educational Grant from AstraZeneca
podcast Podcast
Oncology 
Prostate Cancer Highlights from ASCO GU 2022

Experts
Assoc. Prof. Alicia Morgans, Dr Neal D. Shore
  • download Downloadable
    Resources
  • clock MIN
  • calendar Mar 2022

Educational programme supported by an Independent Educational Grant from Bayer
podcast Podcast

Episode

3

of 3

episode
  • download Downloadable
    Resources
  • clock MIN
  • calendar Jan 2022

Educational programme supported by an Independent Educational Grant from AstraZeneca